AI health companion, Ada Health intensifies collaboration with German Accelerator Life Sciences (GALS) as it expands to the US. Following the successful closing of a $47M funding round, Ada will accelerate operational and partnership developments in a rapidly growing US market. The London and Berlin-based health technology company has developed a health companion and telemedicine app as well as a decision support tool for medical professionals, which launched in late 2016.
Circadian rhythms, widely referred to as the 'body clock', allows people's bodies to predict their needs over the dark and light periods of the day.
| Location: | Bristol, United Kingdom |
| Job Type: | Full-Time |
| Employer: | University of Bristol |
| Closing Date: | 02 January 2018 |
The Personal Connected Health Alliance (PCHAlliance) today released the latest version of the Continua Design Guidelines (CDGs) to enable the secure, private, reliable and accurate sharing of patient generated health data (PGHD) with healthcare providers, built-on HL7 FHIR (Fast Healthcare Interoperability Resources) specifications. The Design Guidelines now support the integration of personal health data from
17 - 19 April 2018, Stuttgart, Germany.
The progress in computer modelling and simulation applied in disease management is a European strength and various Decision Support Systems have been developed for different medical disciplines. While the market is developing today, addressing the need of more precise and personalised diagnostics and treatments, the proposed software tools and platforms often need to further conquer visibility and trust from users and investors to get implemented in the routine clinical practice.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has acquired VitalHealth, a leading provider of cloud-based population health management solutions for the delivery of personalized care outside of the hospital, for example, in regional care networks.
Royal Philips (NYSE: PHG, AEX: PHIA), a leader in health technology, is pleased to be associated with the government's recently announced £4.7 billion Industrial Strategy Challenge Fund. Working with public bodies, industry colleagues, the Office of Life Sciences and the Department of Business, Energy and Industrial Strategy, Philips will contribute to the development of artificial intelligence (AI) based and digital diagnostic solutions at scale.